Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	38308
Country	China

Received	2018-02-07 09:27
Peer-Review Started	2018-02-07 10:38
To Make the First Decision	2018-03-09 07:35
Return for Revision	2018-03-15 06:52
Revised	2018-03-23 12:55
Second Decision	2018-04-16 00:46
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2018-04-16 04:26
Articles in Press	2018-04-16 04:26
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-04-30 06:34
Publish the Manuscript Online	2018-05-15 07:28

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Risk of gastric cancer development after eradication of Helicobacter pylori
Manuscript Source	Invited Manuscript
All Author List	Ka-Shing Cheung and Wai K Leung
ORCID	Author(s) ORCID Number Ka-Shing Cheung http://orcid.org/0000-0002-4838-378X Wai K Leung http://orcid.org/0000-0002-5993-1059
Funding Agency and Grant Number
Corresponding Author	Wai K Leung, MBChB, MD, MRCP, Doctor, Professor, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong , China. waikleung@hku.hk
Key Words	Gastric adenocarcinoma; Stomach cancer; Helicobacter pylori; Chemoprevention; Intestinal metaplasia
Core Tip	Although helicobacter pylori (H. pylori) infection is the most important risk factor for gastric cancer (gc) development, eradication of this bacteria does not guarantee the elimination of GC risk, as pre-neoplastic lesions may have already developed. It is therefore necessary to identify patients at high-risk for GC after H. pylori eradication by either endoscopy with histologic assessment or non-invasive testing. Long-term endoscopic surveillance is advisable for high-risk patients. Future studies are necessary to investigate medications that may modify the GC risk after H. pylori eradication.
Publish Date	2018-05-15 07:28
Citation	Cheung KS, Leung WK. Risk of gastric cancer development after eradication of Helicobacter pylori. World J Gastrointest Oncol 2018; 10(5): 115-123
URL	http://www.wjgnet.com/1948-5204/full/v10/i5/115.htm
DOI	http://dx.doi.org/10.4251/wjgo.v10.i5.115

Full Article (PDF)	WJGO-10-115.pdf
Full Article (Word)	WJGO-10-115.doc
Manuscript File	38308-Review.docx
Answering Reviewers	38308-Answering reviewers.pdf
Audio Core Tip	38308-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	38308-Conflict-of-interest statement.pdf
Copyright License Agreement	38308-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	38308-Language certificate.pdf
Peer-review Report	38308-Peer-review(s).pdf
Scientific Editor Work List	38308-Scientific editor work list.pdf